ArticleTrials2019

Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial.

Yuerong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.